Elevance Health (NYSE:ELV) is set to give its latest quarterly earnings report on Wednesday, 2026-01-28. Here’s what investors need to know before the announcement.
Analysts estimate that Elevance Health will report an earnings per share (EPS) of $3.10.
The announcement from Elevance Health is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It’s worth noting for new investors that guidance can be a key determinant of stock price movements.
Historical Earnings Performance
In the previous earnings release, the company beat EPS by $1.07, leading to a 1.3% drop in the share price the following trading session.
Here’s a look at Elevance Health’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 4.96 | 9.19 | 11.38 | 3.86 |
| EPS Actual | 6.03 | 8.84 | 11.97 | 3.84 |
| Price Change % | -1.00 | -8.00 | 3.00 | 0.00 |
Market Performance of Elevance Health’s Stock
Shares of Elevance Health were trading at $376.93 as of January 26. Over the last 52-week period, shares are down 15.92%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
Insights Shared by Analysts on Elevance Health
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Elevance Health.
The consensus rating for Elevance Health is Outperform, based on 8 analyst ratings. With an average one-year price target of $392.38, there’s a potential 4.1% upside.
Comparing Ratings Among Industry Peers
The below …